Literature DB >> 4521468

Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.

G P Bodey, C A Coltman, E J Freireich, J D Bonnet, E A Gehan, A B Haut, J S Hewlett, K B McCredit, J H Saiki, H E Wilson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4521468     DOI： 10.1001/archinte.133.2.260

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  7 in total

1.  Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.

Authors:  Todd L Rosenblat; Michael R McDevitt; Deborah A Mulford; Neeta Pandit-Taskar; Chaitanya R Divgi; Katherine S Panageas; Mark L Heaney; Suzanne Chanel; Alfred Morgenstern; George Sgouros; Steven M Larson; David A Scheinberg; Joseph G Jurcic
Journal:  Clin Cancer Res       Date:  2010-09-21       Impact factor: 12.531

2.  Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.

Authors:  B Lönnqvist; B Andersson; M Björkholm; L Engstedt; G Gahrton; R Hast; G Holm; A Killander; B Lantz; D Lockner; H Mellstedt; J Palmblad; C Paul; C Peterson; B Simonsson; A M Stalfelt; A M Udén; B Wadman; G Oberg
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Remission-induction regimens in acute nonlymphocytic leukemia.

Authors:  D C Brennan; J P Lewis
Journal:  West J Med       Date:  1980-10

4.  [Pharmakokinetics of hydroxy-urea. Therapy of acute myeoblastic leukemias using synchronization and recruitment effects (author' transl)].

Authors:  H Sauer; R Pelka; W Wilmanns
Journal:  Klin Wochenschr       Date:  1976-03-01

5.  Remission induction and remission maintenance in adult acute nonlymphocytic leukemia employing a modified cytostatic (COAP) regimen.

Authors:  D Gerecke; W D Hirschmann; R Voigtmann; R Gross
Journal:  Blut       Date:  1979-07

6.  Remission maintenance therapy in acute myelogenous leukemia.

Authors:  S H Embury; L Elias; P H Heller; C E Hood; P L Greenberg; S L Schrier
Journal:  West J Med       Date:  1977-04

7.  Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors:  M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.